Cardiac MRI for Fabry Disease

Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI

Recruiting N/A Interventional Study
Fabry Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
300 (estimated)
Sponsor
University Health Network, Toronto · Other
Who this trial is looking for

This trial is looking for adults with Fabry disease to see if a special heart scan can find early heart problems. Participants will undergo cardiac MRI tests to help understand their condition better.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have Fabry disease
  • I am 18 years or older

You may not be able to join if

  • I have had a heart attack
  • I cannot have an MRI scan

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase risk of adverse events.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Fabry disease; * Age ≥ 18 years. Exclusion Criteria: * History of myocardial infarction; * Contraindication to MRI.
Contacts

Kate Hanneman

416-323-6400

kate.hanneman@uhn.ca

CONTACT